Ankara Etlik City Hospital
Ankara, Yenimahalle, 06170, Turkey (Türkiye)
NCT Number: NCT06739460
This study aims to compare the antinociceptive effects of ketamine and magnesium used in addition to midazolam, fentanyl, propofol and remifentanil agents preferred in hysteroscopy cases. It is conducted to observe the effect of ketamine and magnesium use on total additional propofol doses and additional remifentanil doses.
Interested in participating?
Request Info18 year–55 year
Female
Observational
Ankara, Yenimahalle, 06170, Turkey (Türkiye)
Sedation is generally preferred in hysteroscopy cases. The most commonly used intravenous drugs are midazolam, fentanyl, propofol and remifentanil. Multimodal analgesia, which is intended to be provided in hysteroscopy cases, is a strategy that includes the use of two or more analgesic agents and techniques to provide adequate analgesia; and aims to minimize side effects such as bradycardia, hypotension, respiratory depression, pruritus, and postoperative nausea and vomiting. Multimodal analgesia improves patient and surgical comfort by applying additional drugs to existing agents, reduces postoperative complications, and thus helps to shorten hospital stays and reduce costs. Whether magnesium contributes to this multimodal analgesia will be investigated observationally, based on its antinociceptive effects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: During the hysteroscopic procedures.
Observe the effect of ketamine and magnesium use on total additional doses of propofol and additional doses of remifentanil.
SULEYMAN SARI
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07173231
Anxiety, Anxiety Disorders
View Trial DetailsNCT06637111
Hysteroscopy, Neurologic Manifestations
Cairo, Egypt
View Trial DetailsNCT06642311
Hysteroscopy, Neurologic Manifestations
Cairo, Egypt
View Trial DetailsNCT06558370
Hysteroscopy, Neurologic Manifestations
Cairo, Egypt
View Trial Details